19-55489389-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001144950.2(SSC5D):c.88G>A(p.Ala30Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000029 in 1,481,554 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000028 ( 1 hom. )
Consequence
SSC5D
NM_001144950.2 missense
NM_001144950.2 missense
Scores
1
3
15
Clinical Significance
Conservation
PhyloP100: 0.767
Genes affected
SSC5D (HGNC:26641): (scavenger receptor cysteine rich family member with 5 domains) Predicted to enable fibronectin binding activity; laminin binding activity; and scavenger receptor activity. Predicted to be involved in defense response; detection of bacterial lipoprotein; and negative regulation of interleukin-8 production. Predicted to act upstream of or within regulation of interleukin-8 production. Predicted to be located in collagen-containing extracellular matrix. Predicted to be active in extracellular matrix and extracellular space. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3154507).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SSC5D | NM_001144950.2 | c.88G>A | p.Ala30Thr | missense_variant | 3/14 | ENST00000389623.11 | NP_001138422.1 | |
SSC5D | NM_001195267.2 | c.88G>A | p.Ala30Thr | missense_variant | 3/13 | NP_001182196.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SSC5D | ENST00000389623.11 | c.88G>A | p.Ala30Thr | missense_variant | 3/14 | 1 | NM_001144950.2 | ENSP00000374274.4 | ||
SSC5D | ENST00000587166.5 | c.88G>A | p.Ala30Thr | missense_variant | 3/13 | 1 | ENSP00000467252.1 | |||
SSC5D | ENST00000594321.5 | c.88G>A | p.Ala30Thr | missense_variant | 3/3 | 4 | ENSP00000470226.1 | |||
SSC5D | ENST00000588254.1 | n.502G>A | non_coding_transcript_exon_variant | 2/5 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152248Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
6
AN:
152248
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000278 AC: 37AN: 1329190Hom.: 1 Cov.: 31 AF XY: 0.0000337 AC XY: 22AN XY: 653612
GnomAD4 exome
AF:
AC:
37
AN:
1329190
Hom.:
Cov.:
31
AF XY:
AC XY:
22
AN XY:
653612
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152364Hom.: 0 Cov.: 32 AF XY: 0.0000268 AC XY: 2AN XY: 74512
GnomAD4 genome
AF:
AC:
6
AN:
152364
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74512
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 31, 2024 | The c.88G>A (p.A30T) alteration is located in exon 3 (coding exon 3) of the SSC5D gene. This alteration results from a G to A substitution at nucleotide position 88, causing the alanine (A) at amino acid position 30 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;L
PrimateAI
Pathogenic
D
PROVEAN
Benign
.;.;N
REVEL
Benign
Sift
Uncertain
.;.;D
Sift4G
Benign
T;T;T
Polyphen
0.99
.;.;D
Vest4
0.40, 0.39
MutPred
Loss of methylation at R32 (P = 0.1375);Loss of methylation at R32 (P = 0.1375);Loss of methylation at R32 (P = 0.1375);
MVP
MPC
0.11
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at